Zyrtec for kids是什么？

用途

是什么Zyrtec儿童过敏（口服）用于？

• 变应性鼻炎
• 荨麻疹
• 过敏性荨麻疹
• 物理荨麻疹

警告

什么是我应该了解的最重要信息Zyrtec儿童过敏（口服）?

如果您对西替利嗪或左西替利嗪过敏，则不应使用本药。

西替利嗪注射不适用于6岁以下患有肝脏或肾脏疾病的儿童。

询问医生或药剂师服用西替利嗪是否安全口服如果您有任何医疗条件。

如果您怀孕或母乳喂养，请在使用此药物之前询问医生。

在你接受西替利嗪治疗之前注射在紧急情况下，您可能无法告知护理者您的健康状况。确保以后照顾你的任何医生都知道你服用了这种药。

用户评论和评级

整体评级Zyrtec儿童过敏（口服）

副作用

什么是副作用Zyrtec儿童过敏（口服）?

如果你有的话，得到紧急医疗帮助过敏反应的迹象：荨麻疹;呼吸困难;脸上的脸，嘴唇，舌头或喉咙肿胀。

如果您有以下情况，请停止服用此药并立即致电您的医生：

• 快速，冲击或不均匀的心跳;
• 虚弱、颤抖（无法控制的颤抖）或睡眠问题（失眠）；
• 严重不安感、多动症；
• 混乱
• 视力问题；或
• 小便很少或没有小便。

常见的副作用可能包括：

• 困倦、疲倦；
• 头晕，感觉轻盈;
• 感觉热，出汗；
• 麻木，刺痛，灼痛;
• 味觉下降；
• 头痛；
• 胃痛、恶心、便秘；或
• 口干，喉咙痛。

这不是一个完整的副作用列表，可能会出现其他副作用。打电话给你的医生征求关于副作用的医疗建议。您可以致电1-800-FDA-1088向FDA报告副作用。

怀孕和母乳喂养

我能吃点什么吗Zyrtec儿童过敏（口服）如果我怀孕或母乳喂养？

如果您怀孕或母乳喂养，请在使用此药物之前询问医生。

互动

服用时应避免服用什么药物和食物Zyrtec儿童过敏（口服）?

避免驾驶或危险活动，直到你知道这种药物对你的影响。你的反应可能会受到影响。

服用西替利嗪时避免饮酒。

剂量指南和提示

如何服用Zyrtec儿童过敏（口服）?

用Zyrtec儿童过敏（口服）完全按照标签上的指示或医生的处方。不要使用更多或更少的量或超过推荐的时间。

西替利嗪口服是由嘴巴拍摄的。

西替利嗪注射作为静脉输液。医疗保健提供者会根据治疗麻疹的需要，每24小时给你注射一次。

使用西替利嗪口服完全按照标签上的指示或医生的处方。

年龄较大的成年人可能需要低于正常剂量。遵循您的医生的指示。

你可以吃西替利嗪，也可以不吃。

你必须咀嚼食物咀嚼片在你吞下它之前。

不要吞下溶片整体让它在口中溶解而不咀嚼。药片溶解时吞咽几次。如果需要，您可以喝液体帮助吞咽溶解的药片。

量液体药小心。使用提供的剂量注射器，或使用药物剂量测量装置（不是厨房勺子）。

如果你的症状没有改善，如果症状恶化，或者如果你发烧，就给你的医生打电话。

储存在室温下，远离湿气和热量。不要让药水结冰。

如果我错过了一剂，我该怎么办Zyrtec儿童过敏（口服）?

尽快服用药，但如果几乎是你的下一个剂量的时间，请跳过错过的剂量。不要一次服用两剂。

过量迹象

如果我服用过量会发生什么Zyrtec儿童过敏（口服）?

服用过量的症状可能包括极度困倦、视力问题、烦躁、感觉不安，然后昏昏欲睡或疲倦、心跳加快、胃痛、恶心、呕吐、行走困难、吞咽或说话困难。

如果有人在服药后昏倒或无法呼吸Zyrtec儿童过敏（口服），打911

911

图像

Z10

颜色：白色

形状：圆形

风味：柑橘

印迹：Z10

Pregnant woman talking to her doctor about medication use.

In a new CDC study, researchers reviewed more than 50 published scientific articles to see if there was a risk of birth defects from using antihistamines, like allergy medication, during pregnancy. Researchers found the evidence to be generally reassuring: most antihistamines do not appear to be linked to birth defects. However, researchers need to study certain antihistamine medications further to determine if they increase the risk for birth defects. You can read the article’s abstract hereexternal icon. Read more below for a summary of the findings from this article.

Main findings from this study

• Scientific research suggests that using most types of antihistamines during pregnancy is not linked to birth defects.
• Out of 54 studies examined, 9 studies showed potential links between certain antihistamines and certain birth defects. Researchers need to study these potential links further.
• Researchers found many studies on antihistamine medications typically used to treat allergies, asthma, or nausea and vomiting (H1-receptor antagonists).
  • Examples of H1-receptor antagonists include diphenhydramine (Benadryl®), dimenhydrinate (Dramamine®), loratadine (Claritin®), and cetirizine (Zyrtec®).
• In contrast, researchers found relatively few studies on antihistamines typically used to treat indigestion (H2-receptor antagonists).
  • Examples of H2-receptor antagonists include ranitidine (Zantac®), famotidine (Pepcid®), and cimetidine (Tagamet®).

• Talk with your doctor if you are pregnant and you have taken any medicine or are thinking of taking any medicine. This includes prescription and over-the-counter medications, as well as dietary or herbal products.
• Pregnant women should not stop or start taking any type of medication that they need without first talking with a doctor.
• If you are planning a pregnancy and are using any medications, please talk to your doctor about which medications are necessary and should be continued.

About antihistamines and this study

About antihistamines

Antihistamines include both prescription and over-the-counter medications. They typically are used to treat

• Asthma and/or allergies;
• Nausea and vomiting; or
• Indigestion (heartburn or stomach ache).

About 10-15% of women report taking antihistamines during pregnancy.

About this study

Researchers reviewed more than 50 published scientific articles that looked at the link between antihistamine use during pregnancy and birth defects. They evaluated the articles based on certain criteria: how researchers selected their study populations, how researchers determined antihistamine use in pregnancy, and how researchers identified babies with birth defects.

Treating for Two: Safer Medication Use in Pregnancy

In collaboration with federal and external partners, CDC’s Treating for Two initiative is a national strategy to improve the health of mothers and babies through better research, reliable guidance, and informed decisions related to medication treatment in pregnancy.

• Research: CDC funds the Centers for Birth Defects Research and Prevention, which collaborate on large studies such as the National Birth Defects Prevention Study (births 1997-2011) and the Birth Defects Study To Evaluate Pregnancy exposures (started with births in 2014). Researchers engaging in these studies work to identify factors that increase the risk for birth defects and to answer questions about the effects of some medications taken during pregnancy.
• Technical expertise: CDC works with staff from the U.S. Food and Drug Administration (FDA) and other professionals to help conduct studies on the effects of medication use during pregnancy and ways to prevent harmful effects.
• Collaboration: As part of the Treating for Two: Safer Medication Use in Pregnancy Initiative pdf icon[PDF – 1 MB], CDC is committed to working with its partners, other federal agencies, and the public to build a comprehensive approach to improve the quality of data on medication use during pregnancy, translate this information into safe and effective health care for pregnant women, and make this information easily accessible to women and their healthcare providers.

More Information

For more information on medications and pregnancy, visit www.cdc.gov/treatingfortwo

Key Findings Reference

Gilboa SM, Ailes EC, Rai R, Anderson J, Honein MA. Antihistamines and Birth Defects: A Systematic Review of the Literature. Expert Opinion on Drug Safety. 2014. [epub ahead of print]